Pharmaceutical compositions comprising an S1P modulator

Details for Australian Patent Application No. 2011235934 (hide)

Owner Novartis AG

Inventors Carreno-Gomez, Begona; Ruegger, Colleen; Valazza, Stephen; Ambuhl, Michael; Beyer, Jutta

Agent Davies Collison Cave

Pub. Number AU-A-2011235934

Parent 2007302296

Filing date 10 October 2011

Wipo publication date 3 November 2011

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/32 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

27 October 2011 Complete Application Filed

3 November 2011 Application Open to Public Inspection

  Published as AU-A-2011235934

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011235935-Dual pulse-width medical laser with presets

2011235933-Antimicrobial peptides comprising an arginineand/or lysine-containing motif